[HTML][HTML] Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
MI Teixeira, CM Lopes, MH Amaral, PC Costa - Colloids and Surfaces B …, 2023 - Elsevier
The blood-brain barrier (BBB) restricts the access of therapeutic agents to the brain,
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …
[PDF][PDF] Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
MI Teixeira, CM Lopes, MH Amaral… - Colloids and Surfaces B …, 2023 - researchgate.net
The blood-brain barrier (BBB) restricts the access of therapeutic agents to the brain,
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …
Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
MI Teixeira, CM Lopes… - … and surfaces. B …, 2023 - pubmed.ncbi.nlm.nih.gov
The blood-brain barrier (BBB) restricts the access of therapeutic agents to the brain,
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …
Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): a current overview of active targeting in brain diseases
MI Teixeira, CM Lopes, MH Amaral… - Colloids and Surfaces B …, 2023 - bdigital.ufp.pt
The blood-brain barrier (BBB) restricts the access of therapeutic agents to the brain,
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …
Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases.
MI Teixeira, CM Lopes, MH Amaral… - Colloids and surfaces. B …, 2022 - europepmc.org
The blood-brain barrier (BBB) restricts the access of therapeutic agents to the brain,
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …
complicating the treatment of neurological diseases, such as Alzheimer's disease (AD) …